Financials data is unavailable for this security.
View more
Year on year Utah Medical Products Inc had little change in net income (from 16.47m to 16.64m) despite revenues that fell -3.93% from 52.28m to 50.22m.
Gross margin | 58.99% |
---|---|
Net profit margin | 33.56% |
Operating margin | 32.71% |
Return on assets | 12.00% |
---|---|
Return on equity | 12.72% |
Return on investment | 12.43% |
More ▼
Cash flow in USDView more
In 2023, Utah Medical Products Inc increased its cash reserves by 23.74%, or 17.82m. The company earned 22.28m from its operations for a Cash Flow Margin of 44.36%. In addition the company used 639.00k on investing activities and also paid 4.17m in financing cash flows.
Cash flow per share | 5.49 |
---|---|
Price/Cash flow per share | 12.02 |
Book value per share | 35.45 |
---|---|
Tangible book value per share | 30.45 |
More ▼
Balance sheet in USDView more
Current ratio | 25.98 |
---|---|
Quick ratio | 23.68 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
SmartText is unavailable
Div yield(5 year avg) | 1.21% |
---|---|
Div growth rate (5 year) | 1.86% |
Payout ratio (TTM) | 27.46% |
EPS growth(5 years) | 2.27 |
---|---|
EPS (TTM) vs TTM 1 year ago | -8.76 |
More ▼